HCPLive
@HCPLiveNews
Everything you need to enhance your clinical approach to improving patient care.
It's a new day here at #DERM2025 @DermNPPA! Recent data in the #dermatology space and new interviews with leaders in the field are being released all day, with our coverage continuing through the weekend. Check out our latest coverage here 👇 hcplive.com/conference/der…




How should clinicians approach #AI in dermatology?🖥️ What are the biggest concerns?🤔 Find out Dr. David Cotter's responses to these questions in this #DERM2025 interview, available here: hcplive.com/view/how-to-us…
I can't believe what a quick trip to Vegas that was for #DERM2025! That said, we are still releasing all the recent data and interviews from the conference that we feel you might care about as a clinician or patient in #dermatology. Check out the latest: hcplive.com/conference/der…
ICYMI: In a new interview at the @DermNPPA #DERM2025 conference, Linda Stein Gold, MD, of @HenryFordHealth, spoke with HCPLive about topical options for #psoriasis outside of topical corticosteroids. View her responses: hcplive.com/view/highlight…
Adam Friedman, MD, of @GW_MFA spoke with HCPLive about off-label approaches to therapeutic challenges in conditions such as #LichenPlanus. View more here: hcplive.com/view/off-label…
Lisa Swanson, MD, was asked at #DERM2025 about tips for clinicians on communicating with the parents of patients in #dermatology practices. Check out her responses here: hcplive.com/view/tips-deal…
At #DERM2025: Eingun James Song, MD, highlighted some of the biggest takeaways from his team’s phase 4 research in the UnlIMMited study on risankizumab for genital and scalp #psoriasis. 🔗View the discussion of these findings: hcplive.com/view/new-findi…
At #DERM2025: Recent data suggests that lebrikizumab effectively controls #AtopicDermatitis in patients with low BSA involvement and high #itch, a commonly underrepresented subpopulation in research. View more here: hcplive.com/view/patients-…
Are you caught up with the dermatology news covered at the #DERM2025 meeting in Las Vegas? We've got you covered! Check out the latest news, including on-site interviews with leaders in the field and recent data in different disease states. 🔗View here: hcplive.com/conference/der…


Tralokinumab (Adbry) therapy for up to 9 months reduces head and neck #AtopicDermatitis severity and improves quality of life, new data suggest. Improvements were consistent across both dupilumab-naïve and experienced patients. View more here: hcplive.com/view/tralokinu… #DERM2025
Using GLP-1 RAs and SGLT2 inhibitors together substantially reduces 1-year mortality and hospitalizations in patients with heart failure and atherosclerotic cardiovascular disease. Read now: hubs.li/Q03y-v450
Lisa A. Swanson, MD, of @AdaWestDerm spoke about several tips for clinicians treating #acne in pediatric patients. She highlights that younger patients are starting to show signs of teenage acne, noting theories about why this shift is occurring. 🔗View: hcplive.com/view/advice-sy…
New findings show chronic spontaneous #urticaria (#CSU) affects 0.78% of U.S. adults, far more than previous estimates. Most patients face high mental, physical, and work-related burdens, yet few see dermatologists. hubs.ly/Q03y-tLZ0
At #DERM2025: J. Scott Boswell, MD, spoke on-site with the team about clinical pearls related to combining systemic treatments for #psoriasis and #AtopicDermatitis. 🔗View: hcplive.com/view/clinical-…
More news from the #DERM2025 Las Vegas conference is coming your way today! Want to stay informed on recent #dermatology data and interviews with leaders in the field?🤔 View the latest updates here: hcplive.com/conference/der…


Ritlecitinib (Litfulo) 50 mg showed long-term efficacy in treating #AlopeciaAreata in patients aged 12 and older, new data suggest, with significant SALT score improvements over 24 months. Learn more about these findings, presented at #DERM2025, here: hcplive.com/view/phase-3-f…
"...We have biologics for psoriasis, we have biologics and systemic treatments like JAK inhibitors for atopic dermatitis, and soon we may need to be thinking as clinicians about using both to manage their disease process.” View this #DERM2025 interview: hcplive.com/view/clinical-…
Are you up-to-date on news covered at @DermNPPA #DERM2025? If not, check out our latest coverage of recent data and interviews with experts in the field of #dermatology such as Drs. Adam Friedman, Suneel Chilukuri, Linda Stein Gold, and Lisa Swanson! hcplive.com/conference/der…


A recent study has established the efficacy of SGLT2 inhibitors in reducing myocardial fibrosis, cardiac structure, and metabolic control in patients with heart failure with preserved ejection fraction and type 2 #diabetes. Read more: hubs.ly/Q03y-v6R0
At #DERM2025 in Las Vegas: Suneel Chilukuri, MD, spoke with HCPLive about the biggest takeaways from his talk ‘Skincare Secrets and Quick Fixes.’ View more here: hcplive.com/view/discussin…
New research reveals a paradox in severe allergic asthma: patients report worse physical health but show stronger emotional defenses than those with venom anaphylaxis. Read more about the study here: hubs.li/Q03y-tWH0